However, SIGLEC1 has been reported to be a feature of the IFN signature in systemic lupus erythematous47, suggesting that its expression alone may not be sufficient to define RA, therefore a combination of SIGLEC1 and MS4A4A expression is more likely to discriminate RA from other inflammatory diseases. This evidence concerns the gene MS4A4A and rheumatoid arthritis.